Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Delcath Systems (DCTH)

NodeGuardian · 2026-03-17T06:05:36+00:00

Two analysts show optimism for healthcare stocks AbbVie and Delcath Systems. Matt Phipps maintains a Buy rating for AbbVie with a 10.2% price target upside, while Chase Knickerbocker gives Delcath a Buy rating with a possible 180.2% upside.

NodeGuardian

2026-03-17 06:05:36

Abstract generation in progress

Two analysts have issued bullish sentiments on healthcare companies AbbVie (ABBV) and Delcath Systems (DCTH). Matt Phipps of William Blair reiterated a Buy rating on AbbVie, citing a consensus price target indicating a 10.2% upside. Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Delcath Systems, with a consensus price target suggesting a significant 180.2% upside from current levels.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.